Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Conferences
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
General Assembly
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
10 Jan 2019 - 11 Jan 2019
Oddo BHF Forum, Lyon, France
07 Jan 2019 - 10 Jan 2019
37th Annual J.P. Morgan Healthcare Conference, San Francisco (CA), USA
06 Nov 2018 - 08 Nov 2018
World Orphan Drug Congress Europe, Barcelona, Spain
12 October 2018
GenSight Biologics to present REVERSE data with GS010 at the 2018 Annual Meeting of the American Academy of Ophthalmology
09 October 2018
GenSight Biologics to participate in multiple upcoming investor conferences
22 Nov 2018 - 23 Nov 2018
Salon Actionaria 2018, Paris, France
23 Oct 2018 - 24 Oct 2018
2nd Annual Gene Therapy for Rare Disorders Europe, London, UK
25 Oct 2018
Ophthalmology Innovation Summit @ AAO, Chicago (IL)
27 Oct 2018 - 30 Oct 2018
American Academy of Ophthalmology, Chicago (IL)
09 Oct 2018
Chardan 2nd Annual Genetic Medicines Conference, NYC (US)
View previous 9 articles
1
…
5
6
7
8
9
10
11
12
View next 9 articles
Go back to the page of the page